Serono Luveris Data Support Follicular Development Indication, Cmte. Says
Executive Summary
Serono's Luveris data are sufficient to support a follicular development indication in infertile hypogonadotropic hypogonadal women with severe luteinizing hormone deficiency, FDA's Reproductive Health Drugs Advisory Committee said Sept. 30